Renal cell cancer histological subtype distribution differs by race and sex

BJU International

Volumn 117, Issue 2, 2016, Pages 260-265

  Lipworth, Loren ^a,b   Morgans, Alicia K ^a,b   Edwards, Todd L ^a,b,c   Barocas, Daniel A ^a,b   Chang, Sam S ^a,b   Duke Herrell, S ^a,b   Penson, David F ^a,b   Resnick, Matthew J ^a,b   Smith, Joseph A ^a,b   Clark, Peter E ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

end stage renal disease; histology; race; renal cell cancer; sex

Indexed keywords

ADULT; AGED; ARTICLE; BLACK PERSON; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; ETHNICITY; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYNDROME DELINEATION; AFRICAN AMERICAN; ASIAN AMERICAN; CARCINOMA, RENAL CELL; HISPANIC; INCIDENCE; KIDNEY NEOPLASMS; NEPHRECTOMY; ODDS RATIO; PATHOLOGY; PROGNOSIS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; ASIAN AMERICANS; CARCINOMA, RENAL CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEPHRECTOMY; ODDS RATIO; PROGNOSIS; RISK FACTORS; UNITED STATES;

EID: 84954365468     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12950     Document Type: Article

References (22)

1. Siegel R, Ma J, Zou Z, Jemal A,. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29
2. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100: 1672-1694
3. Lipworth L, McLaughlin JK, Tarone RE, Blot WJ,. Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Eur J Cancer Prev 2011; 20: 331-333
4. Lipworth L, Tarone RE, McLaughlin JK,. Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer 2011; 11: 133
5. DeSantis C, Ma J, Bryan L, Jemal A,. Breast cancer statistics, 2013. CA Cancer J Clin 2014; 64: 52-62
6. Sankin A, Cohen J, Wang H, Macchia RJ, Karanikolas N,. Rate of renal cell carcinoma subtypes in different races. Int Braz J Urol 2011; 37: 29-32
7. Qi P, Tsivian M, Abern MR, Passoni NM, McGinley KF, Polascik TJ,. Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans. Urol Oncol 2014; 32: 555-560
8. Purdue MP, Moore LE, Merino MJ, et al. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer 2013; 132: 2640-2647
9. Begg CB, Zhang ZF,. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 1994; 3: 173-175
10. Olshan AF, Kuo TM, Meyer AM, Nielsen ME, Purdue MP, Rathmell WK,. Racial difference in histologic subtype of renal cell carcinoma. Cancer Med 2013; 2: 744-749
11. Lipworth L, Mumma MT, Cavanaugh KL, et al. Incidence and predictors of end stage renal disease among low-income blacks and whites. PLoS One 2012; 7: e48407
12. Bash LD, Astor BC, Coresh J,. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2010; 55: 31-41
13. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Hernandez GT, O'Hare AM,. White/black racial differences in risk of end-stage renal disease and death. Am J Med 2009; 122: 672-678
14. McClellan WM, Warnock DG, Judd S, et al. Albuminuria and racial disparities in the risk for ESRD. J Am Soc Nephrol 2011; 22: 1721-1728
15. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845
16. Pollak MR, Genovese G, Friedman DJ,. APOL1 and kidney disease. Curr Opin Nephrol Hypertens 2012; 21: 179-182
17. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H,. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003; 170: 2217-2220
18. Geronimus AT, Bound J, Waidmann TA, Hillemeier MM, Burns PB,. Excess mortality among blacks and whites in the United States. N Engl J Med 1996; 335: 1552-1558
19. Purdue MP, Moore LE, Merino MJ, et al. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer 2013; 132: 2640-2647
20. Lipworth L, Tarone RE, Lund L, McLaughlin JK,. Epidemiologic characteristics and risk factors for renal cell cancer. Clin Epidemiol 2009; 1: 33-43
21. Flegal KM, Carroll MD, Kit BK, Ogden CL,. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497
22. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008; 32: 1239-1245